Business Engagement (Collaborative Opportunities with UCB Pharma in the area of Immunology)

Within the College we have over 60 companies who we are currently working with to carry out collaborative research, contract research or CASE studentships.

One of our closest ties is with UCB Pharma, and an opportunity for research into immunology has opened up via the Centre of Collaborative Research

UCB Pharma (also known as UCB Celltech) – http://www.ucbpharma.co.uk
Establishing successful partnerships is fundamental to the success of UCB as the complexities of severe diseases are beyond the expertise and resource of a single organisation. Through partnerships, UCB can optimise its product pipeline in its core therapeutic areas.

The Centre for Collaborative Research (CfCR), based in Slough, supports collaboration with academics and biotech companies to investigate new targets for possible development.

The CfCR aims to develop new collaborative projects with academic and biotechnology partners by providing access to UCB’s world-class antibody generation and engineering capabilities. The CfCR is currently seeking project proposals in the area of immunology. Key areas of interest include, but are not limited to:

  • rheumatology, for example rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)
  • severe asthma and chronic obstructive pulmonary disease (COPD)
  • osteoarthritis and osteoporosis
  • fibrotic disease and scleroderma
  • immune tolerance

If you would like to explore this opportunity please contact Anne Simper, Business Engagement Partner MDS, on 07717 441 014 or a.simper@bham.ac.uk

Advertisements